Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease (Q65351039)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease
clinical trial

    Statements

    CATS29 (English)
    0 references
    A Phase IIb, Multicentre, Randomised, Double-blinded, Placebo-controlled, Multi-dose and Multi-injection, Parallel Groups Study to Evaluate the Efficacy and the Safety of Ovasave in Patients With Active Refractory Crohn's Disease (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    December 2014
    0 references
    November 2016
    0 references
    32
    0 references
    18 year
    0 references
    70 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit